Furthermore, this study explored the correlation of N6AMT1 expression with immunomodulators, lymphocyte subset infiltration, and immunotherapy biomarkers, and assessed the potential value of N6AMT1 in immunotherapy in different cancer types. Here, HEMK2 is linked to cancer.